These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 14696795
1. Molecular analysis of neurofibromatosis type 1 in Turkish families using polymorphic markers. Oğuzkan S, Cinbiş M, Ayter S, Anlar B, Aysun S. Turk J Pediatr; 2003; 45(3):192-7. PubMed ID: 14696795 [Abstract] [Full Text] [Related]
2. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling. Terzi YK, Oguzkan-Balci S, Anlar B, Aysun S, Guran S, Ayter S. Genet Couns; 2009; 20(2):195-202. PubMed ID: 19650418 [Abstract] [Full Text] [Related]
3. Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool. Elyakim S, Lerer I, Zlotogora J, Sagi M, Gelman-Kohan Z, Merin S, Abeliovich D. Am J Med Genet; 1994 Dec 01; 53(4):325-34. PubMed ID: 7864041 [Abstract] [Full Text] [Related]
5. [From gene to disease; neurofibromatosis type 1]. de Goede-Bolder A, Cnossen MH, Dooijes D, van den Ouweland AM, Niermeijer MF. Ned Tijdschr Geneeskd; 2001 Sep 08; 145(36):1736-8. PubMed ID: 11572174 [Abstract] [Full Text] [Related]
6. NF1 mutation analysis using a combined heteroduplex/SSCP approach. Abernathy CR, Rasmussen SA, Stalker HJ, Zori R, Driscoll DJ, Williams CA, Kousseff BG, Wallace MR. Hum Mutat; 1997 Sep 08; 9(6):548-54. PubMed ID: 9195229 [Abstract] [Full Text] [Related]
7. Neurofibromatosis: novel and recurrent mutations in Turkish patients. Terzi YK, Oguzkan S, Anlar B, Aysun S, Ayter S. Pediatr Neurol; 2007 Dec 08; 37(6):421-5. PubMed ID: 18021924 [Abstract] [Full Text] [Related]
9. Genetic and clinical considerations in six cases with neurofibromatosis type 1. Buteică E, Stoicescu I, Burada F, Stănoiu B. Rom J Morphol Embryol; 2007 Dec 08; 48(3):243-8. PubMed ID: 17914490 [Abstract] [Full Text] [Related]
10. A de novo Alu insertion results in neurofibromatosis type 1. Wallace MR, Andersen LB, Saulino AM, Gregory PE, Glover TW, Collins FS. Nature; 1991 Oct 31; 353(6347):864-6. PubMed ID: 1719426 [Abstract] [Full Text] [Related]
12. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1? Yang CC, Happle R, Chao SC, Yu-Yun Lee J, Chen W. J Am Acad Dermatol; 2008 Mar 31; 58(3):493-7. PubMed ID: 18280349 [Abstract] [Full Text] [Related]
14. [Genetics of type 1 neurofibromatosis]. Garavelli L, Donadio A, Sigorini M, Grassi L, Banchini G. Acta Biomed Ateneo Parmense; 2000 Mar 31; 71(3-4):89-95. PubMed ID: 11424621 [Abstract] [Full Text] [Related]
15. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis]. Crişan M, Talu S, Florea M, Coprean D, Cosgarea R, Crişan D. Oftalmologia; 2008 Mar 31; 52(4):56-61. PubMed ID: 19354164 [Abstract] [Full Text] [Related]
16. Alport syndrome. Molecular genetic aspects. Hertz JM. Dan Med Bull; 2009 Aug 31; 56(3):105-52. PubMed ID: 19728970 [Abstract] [Full Text] [Related]